FDA approves Lucentis for vision loss-related disease Orphan drug designation for Tolera's diabetes drug Cephalon expands When Good Medicines Become Bad Drugs program with new partnership New FDA-approved test first to detect HIV antigen, antibodies Roche implements risk-mitigation plan for taspoglutide Ferring launches Lysteda Novartis’ Tasigna receives nod from FDA Benlysta could become first lupus treatment in 50 years Clinical trial for Merck KGaA's cancer vaccine continues Study: Celebrex less likely to cause GI issues than other NSAIDs First Previous 189 190 191 192 193 Next Last